Bastian von Tresckow

43PUBLICATIONS
235CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biomechanical engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 21, 2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

|Jul 01, 2026
Feasibility and safety of rapid glofitamab ramp-up.

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Jun 10, 2026
Brentuximab vedotin after alloSCT for relapsed/refractory Hodgkin lymphoma: GHSG BV-ALLO phase 2 trial.

|Jun 02, 2026
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

|Apr 02, 2026
Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Anne Sophie Robertz, Ina Bühnen, Julia Meissner

Pageof 8

Frequent Collaborators

12 joint publications

Paul Jan Bröckelmann

8 joint publications

Dennis A Eichenauer

8 joint publications

Vladan Vucinic

7 joint publications

Carsten Kobe